KR20000045575A - Antioxidant cosmetic composition containing the seed extract of arctium lappa - Google Patents
Antioxidant cosmetic composition containing the seed extract of arctium lappa Download PDFInfo
- Publication number
- KR20000045575A KR20000045575A KR1019980062135A KR19980062135A KR20000045575A KR 20000045575 A KR20000045575 A KR 20000045575A KR 1019980062135 A KR1019980062135 A KR 1019980062135A KR 19980062135 A KR19980062135 A KR 19980062135A KR 20000045575 A KR20000045575 A KR 20000045575A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- cream
- arctium lappa
- cosmetic composition
- antioxidant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 우방(Arctium lappa)의 열매에서 분리정제한 추출물을 함유하는 화장료에 관한 것으로, 구체적으로는 항산화 작용이 뛰어나 피부노화를 방지 또는 지연시키고 천연의 물질이어서 안전한 항산화 화장료에 관한 것이다.The present invention relates to a cosmetic containing an extract separated from the fruit of the locust (Arctium lappa), and specifically relates to a safe antioxidant cosmetic because it is excellent in antioxidant activity to prevent or delay skin aging and is a natural substance.
피부의 노화는 자유 라디칼(free radical)에 의한 생체물질의 산화적 손상에 기인한다. 즉 과산화수소, 히드록시 라디칼, 슈퍼옥사이드 라디칼 등의 활성산소와 같은 반응성이 높은 자유 라디칼은 세포막을 구성하는 지질을 과산화시켜 세포막을 파괴하고 단백질을 산화시키며 핵산을 공격하여 산화적 손상을 일으켜 생체물질을 파괴하고 결국 세포를 죽게한다.Aging of the skin is due to oxidative damage of biomaterials by free radicals. In other words, highly reactive free radicals such as hydrogen peroxide, hydroxy radicals, and superoxide radicals, such as free radicals, peroxidize lipids that make up cell membranes, destroy cell membranes, oxidize proteins, and attack nucleic acids, causing oxidative damage. Destroy and eventually kill the cells.
따라서 피부의 노화 방지 또는 지연은 생체물질의 산화적 손상을 억제함으로써 가능하게 된다.Thus, preventing or delaying aging of the skin is made possible by suppressing oxidative damage of the biomaterial.
화장료의 목표는 아름답고 건강한 피부를 유지하는 것이며, 아울러 나이가 들면서 자연적으로 생기는 피부의 노화를 지연시키는 데 있다. 이를 위해 여러 천연식물성분들의 피부생리활성을 검색하여 안전성이 우수하고 피부 미용 효과가 우수한 물질들을 개발하기 위한 연구가 현재 활발히 진행되고 있다.The goal of cosmetics is to maintain beautiful and healthy skin, and to delay the aging of skin that occurs naturally with age. To this end, research is being actively carried out to develop materials having excellent safety and beauty effects by searching for skin physiological activity of various natural plant components.
지금까지 항산화작용을 갖는 것으로 알려진 물질은 아스코르빈산(ascorbic acid), 디엘-알파토코페롤(dl-α-tocopherol), 베타카로틴(β-carotene), 디부틸히드록실톨루엔(BHT) 등이 있다.Materials known to have antioxidant activity so far include ascorbic acid, DL-alpha-tocopherol, beta-carotene, dibutylhydroxytoluene (BHT), and the like.
그러나 이러한 물질들은 합성품으로 사용되기 때문에 장기 사용시 또는 다량 사용시 피부 안전성의 문제를 일으킬 수 있으므로 보다 안전하고 유용하게 피부에 적용할 수 있는 새로운 항산화 화장료의 개발이 절실하게 요구되고 있는 실정이다.However, since these substances are used as synthetic products, they may cause skin safety problems in long-term use or in large amounts, and thus, there is an urgent need for the development of new antioxidant cosmetics that can be applied to the skin more safely and usefully.
본 발명자들은 피부노화를 방지하는 물질을 검색하기 위하여 여러가지 식물추출물을 대상으로 연구한 결과, 우방의 열매인 우방자로부터 얻은 추출물이 항산화작용이 크다는 것을 알게 되어 본 발명을 완성하게 되었다.The present inventors studied various plant extracts to search for substances that prevent skin aging. As a result, the present inventors have found that extracts obtained from allies, which are the fruits of allies, have a large antioxidant activity, thereby completing the present invention.
우방은 국화과(Compositae)에 속하는 식물로서 한국, 일본과 중국 등지에서 자생하고 있으며, 우방자(Arctii Fructus)는 우방의 열매로서 그 성분은 리그난(lignan)으로서 악티게닌(arctigenin), 리그난배당체로서 악틴(arctiin) 등이 알려져 있으며(T. Namba, The encyclopedia of Wakan-Yaku with Color Pictures, Vol I, pp208, Hoikusha, Tokyo, 1993), 한방에서는 풍습은진, 인후풍열(咽喉風熱)을 치료하며, 여러 종(腫)과 창양독(瘡瘍毒)에 사용되고 있다.Allium is a plant belonging to the family Apothecary (Compositae), which grows in Korea, Japan, and China.Arctii Fructus is the fruit of the ally, and its composition is lignan, actintigenin, and lignan glycoside. arctiin) and others (T. Namba, The encyclopedia of Wakan-Yaku with Color Pictures, Vol I, pp208, Hoikusha, Tokyo, 1993). It is used for species and changyang poison.
본 발명의 목적은 항산화 작용으로 피부노화를 방지 또는 지연시키는 천연물질인 우방자추출물을 함유하는 화장료를 제공하는 것이다.It is an object of the present invention to provide a cosmetic containing an allergy extract, which is a natural substance that prevents or delays skin aging due to antioxidant activity.
본 발명은 우방자에서 얻은 추출물을 함유하는 항산화작용 화장료에 관한 것이다.The present invention relates to an antioxidant cosmetic containing an extract obtained from allies.
본 발명의 화장료에 함유되는 우방자 추출물은 우방자로부터 통상적인 추출방법에 의하여 추출된다. 즉, 우방자를 건조시키고 분쇄하여 미세한 분말로 만든 후, 추출용매를 가하여 실온에서 1~15일간 침적시켜 유효성분을 추출한다. 이때 추출용매로는 물, 저급알코올, 물과 저급알코올의 혼합용매, 아세톤, 디에틸에테르, 클로로포름, 헥산 또는 에틸아세테이트를 사용할 수 있으며, 우방자의 미세분말 1kg에 대하여 1~15ℓ의 추출용매를 사용하는 것이 바람직하다. 이렇게 추출한 추출용액을 감압농축시켜 우방자 추출물로 하고, 이를 화장료에 첨가한다. 이때 화장료에 첨가되는 우방자 추출물은 화장료에 대하여 0.001~10중량%, 바람직하게는 0.01~5중량%이다.The alligator extract contained in the cosmetic of the present invention is extracted from the alligator by a conventional extraction method. In other words, after drying and grinding allies to make a fine powder, the extraction solvent is added to immerse at room temperature for 1 to 15 days to extract the active ingredient. At this time, the extraction solvent may be water, lower alcohol, mixed solvent of water and lower alcohol, acetone, diethyl ether, chloroform, hexane or ethyl acetate, 1 ~ 15ℓ of extraction solvent for 1kg of the fine powder of allies It is desirable to. The extraction solution thus extracted is concentrated under reduced pressure to form an allium extract, which is added to the cosmetic. At this time, the allium extract added to the cosmetic is 0.001 to 10% by weight, preferably 0.01 to 5% by weight relative to the cosmetic.
본 발명의 항산화 화장료는 유연화장수(스킨), 수렴화장수, 영양화장수(로션), 영양크림, 맛사지크림, 에센스, 팩 등의 통상의 화장료 형태로 제조될 수 있다.Antioxidant cosmetics of the present invention can be prepared in the form of conventional cosmetics such as softening (skin), astringent cosmetics, nourishing cosmetics (lotion), nutrition cream, massage cream, essence, pack.
이하 본 발명을 상세히 설명하나, 본 발명이 이에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail, but the present invention is not limited thereto.
실시예 1Example 1
정제수로 세척하고 건조한 후 분쇄한 우방자 미세분말 1kg을 물 4.5ℓ에 넣고 실온에서 15일간 침적한 후 와트만 2번 여과지로 여과하였다. 이 여액을 냉각콘덴서가 달린 감압농축장치에서 농축하여 건조중량 111g을 얻었다.After washing with purified water and drying, 1kg of pulverized milk powder fine powder was placed in 4.5L of water and immersed at room temperature for 15 days, and then filtered with a filter of Whatman 2 times. The filtrate was concentrated in a vacuum condenser with a cooling capacitor to obtain a dry weight of 111 g.
실시예 2~14Examples 2-14
하기 표 1의 추출용매를 사용한 것을 제외하고는 실시예 1과 같은 방법으로 추출하여 우방자추출물을 얻었다.Except for using the extraction solvent of Table 1 was extracted in the same manner as in Example 1 to obtain an allium extract.
실험예 1 : 우방자 추출물의 항산화 작용 시험Experimental Example 1 Antioxidant Test of Allium Extract
실시예 1~14에서 제조한 우방자 추출물에 대하여 항산화 작용을 펜톤반응(Fenton reaction)에 의한 지질과산화반응계(lipid peroxidation system)을 이용한 티오바르비츄릭산법(TBA assay)로 측정하였다.Antioxidant activity was determined by the thiobarbituric acid method (TBA assay) using a lipid peroxidation system by the Fenton reaction.
즉, 에틸리놀레이트 10㎕, 0.2% 소디움도데실설폭시드(SDS), 염화제일철 10
각 추출물의 항산화 효과는 다음의 공식으로 산출하였다.The antioxidant effect of each extract was calculated by the following formula.
그 결과는 하기 표 2에 나타내었다.The results are shown in Table 2 below.
* 3회 평균치* 3 times average
우방자 추출물들은 대부분 높은 활성을 나타내었으며, 비극성용매 및 극성용매의 추출물 모두에서 효과가 컸다.Allium extracts showed high activity, and were effective in both nonpolar and polar solvent extracts.
실험예 2 : 우방자 추출물 및 기존 항산화제들과의 항산화 작용 비교Experimental Example 2 Comparison of Antioxidant Activity between Allium Extract and Existing Antioxidants
실시예 1~14의 우방자 추출물과 기존 항산화제인 아스코르빈산(ascorbic acid), 디엘-알파토코페롤(dl-α-tocopherol), 베타카로틴(β-carotene) 및 디부틸히드록실톨루엔(BHT)의 항산화작용을 실험예 1과 같은 방법으로 측정하여 50% 억제농도인 IC50을 비교하였다.Antioxidants of Allium Extracts of Examples 1 to 14 and Ascorbic Acid, DL-alpha-tocopherol, Beta-carotene, and Dibutylhydroxyltoluene (BHT), Existing Antioxidants The action was measured in the same manner as in Experimental Example 1 to compare the IC 50 of 50% inhibitory concentration.
그 결과는 하기 표 3에 나타낸 바와 같다.The results are as shown in Table 3 below.
실시예 1~14의 우방자 추출물들은 다른 항산화제들에 비교할만한 높은 활성을 나타내었다. 특히 이러한 우방자추출물들은 천연물 혼합물임에도 불구하고 유의할만한 항산화 활성을 가지고 있음을 알 수있다.Allium extracts of Examples 1-14 showed high activity comparable to other antioxidants. In particular, these allium extracts have significant antioxidant activity despite their natural mixture.
실험예 3. 우방자 추출물의 과산화수소 유도 세포독성에 대한 억제효과Experimental Example 3. Inhibitory effect of allium extract on hydrogen peroxide-induced cytotoxicity
실시예 6에서 제조한 우방자 추출물의 과산화수소 유도 세포독성에 대한 억제효과를 마우스유래 피부섬유아세포(fibroblast)를 사용하여 측정하였다.The inhibitory effect on the hydrogen peroxide-induced cytotoxicity of the allium extract prepared in Example 6 was measured using mouse-derived skin fibroblasts.
과산화수소는 세포내에서 히드록실라디칼(hydroxyl radical)을 생성하여 지질과산화를 유발시켜 세포막의 손상과 세포독성을 일으킨다. 우방자 추출물의 항산화작용을 피부세포수준에서 시험하기위하여 다음과 같이 측정하였다.Hydrogen peroxide produces hydroxyl radicals in cells, causing lipid peroxidation, leading to cell membrane damage and cytotoxicity. Antioxidant activity of allium extract was measured as follows to test at the skin cell level.
대수증식기의 마우스 피부섬유아세포를 웰(well)당 10,000개로 96웰 플레이트에 접종하여 디엠이엠(DMEM)배지 80㎕에서 24시간 배양한 후, 배지 중의 최종농도가 10-3M이 되도록 배지에 희석시킨 과산화수소 10㎕를 가하고 동시에 실시예 6의 우방자 추출물의 디메틸설폭시드(DMSO)용액 10㎕을 최종농도가 0, 50, 100, 200, 500㎍/㎖가 되도록 가하여 20시간 추가로 배양한 후, 5mg/㎖의 엠티티(MTT)용액을 15㎕씩 첨가하고 4시간 후에 디메틸설폭시드 용액을 웰당 150㎕씩 가해 용해시킨 다음 마이크로플레이트리더(microplate reader)로 570nm 에서 흡광도를 측정하였다.Inoculate mouse skin fibroblasts of logarithmic growth stage into a 96 well plate at 10,000 cells per well and incubate in 80 µl of DMEM medium for 24 hours, and then dilute the media to a final concentration of 10 -3 M in the medium. 10 μl of hydrogen peroxide was added thereto, and at the same time, 10 μl of the dimethyl sulfoxide (DMSO) solution of the allium extract of Example 6 was added to a final concentration of 0, 50, 100, 200, and 500 μg / ml, followed by further incubation for 20 hours. 15 μl of 5 mg / ml MTT solution was added, and after 4 hours, 150 μl of dimethyl sulfoxide solution was added to the well to dissolve, and the absorbance was measured at 570 nm using a microplate reader.
우방자 추출물의 과산화수소 유도 세포독성에 대한 억제효과는 다음 공식으로 산출하였다.The inhibitory effect on H2O peroxide-induced cytotoxicity was calculated by the following formula.
그 결과는 하기 표 4에 나타낸 바와 같다.The results are as shown in Table 4 below.
* 3회 평균치* 3 times average
우방자 추출물은 과산화수소 유도 세포독성에 대하여 농도의존적으로 억제한 것으로 나타났다. 따라서 우방자 추출물은 마우스 유래 피부섬유아세포내에서 생성된 지질과산화작용을 억제하여 세포독성을 억제하고 있음을 알 수 있다.Allium extract was found to inhibit concentration-dependently on hydrogen peroxide-induced cytotoxicity. Therefore, it can be seen that the ovarian extract inhibits cytotoxicity by inhibiting lipid peroxidation generated in mouse-derived fibroblasts.
실험예4 : 세포독성 실험Experimental Example 4: Cytotoxicity Test
실시예 6에서 제조한 우방자 추출물 자체의 세포독성을 마우스 유래 피부섬유아세포를 사용하여 다음과 같은 방법으로 측정하였다.Cytotoxicity of the alligator extract itself prepared in Example 6 was measured using the mouse-derived dermal fibroblasts as follows.
대수증식기의 마우스 피부섬유아세포를 웰당 10,000개로 96웰 플레이트에 접종하여 디엠이엠(DMEM)배지 80㎕에서 24시간 배양한 후, 실시예 6의 우방자 추출물의 디메틸설폭시드 용액 10㎕을 최종농도가 0, 50, 100, 200, 500 ㎍/㎖가 되도록 가하고 20시간 추가로 배양한 후 5mg/㎖의 MTT 용액을 15㎕씩 첨가하고 4시간 후에 DMSO를 웰당 150㎕ 씩 가해 용해시킨 다음 마이크로플레이트 리더로 570nm에서 흡광도를 측정하였다.Mouse skin fibroblasts of logarithmic growth stage were inoculated into a 96 well plate at 10,000 per well and incubated for 24 hours in 80 µl of DMEM medium, and then 10 µl of the dimethyl sulfoxide solution of the alligator extract of Example 6 was added to a final concentration of 0. , 50, 100, 200, 500 ㎍ / ㎖ added to incubation for 20 hours, 15 μl of 5 mg / ㎖ MTT solution was added, and after 4 hours to dissolve by adding 150 μl of DMSO per well to the microplate reader Absorbance was measured at 570 nm.
우방자 추출물 자체의 세포독성을 세포생존율로서 나타내었으며, 다음 공식에 의해 산출하였다.The cytotoxicity of the alligator extract itself was expressed as cell viability, and was calculated by the following formula.
그 결과는 하기 표 5에 나타낸 바와 같다.The results are as shown in Table 5 below.
* 3회 평균치* 3 times average
실시예 6의 우방자 추출물은 그 자체로서 음성대조군에 비하여 유의성있는 세포독성을 나타내지 않았다.The alligator extract of Example 6 itself did not show significant cytotoxicity compared to the negative control.
처방예 1Prescription Example 1
우방자 추출물을 함유한 화장료중 유연화장수의 처방예는 다음과 같다.The following is an example of the formulation of the flexible cosmetics in the cosmetics containing the allergy extract.
여기서 우방자 추출물은 실시예 6의 것을 말한다.Here, the alliance extract refers to that of Example 6.
처방예 2Prescription Example 2
우방자 추출물을 함유한 화장료중 수렴화장수의 처방예는 다음과 같다.Prescription examples of astringent cosmetics in cosmetics containing allium extract are as follows.
여기서 우방자 추출물은 실시예 6의 것을 말한다.Here, the alliance extract refers to that of Example 6.
처방예 3Prescription Example 3
우방자 추출물을 함유한 화장료중 영양화장수(로션)의 처방예는 다음과 같다.A prescription example of nutrient cosmetic lotion (lotion) in cosmetics containing allium extract is as follows.
여기서 우방자 추출물은 실시예 6의 것을 말한다.Here, the alliance extract refers to that of Example 6.
처방예 4Prescription Example 4
우방자 추출물을 함유한 화장료중 영양크림의 처방예는 다음과 같다.A prescription example of nourishing cream in cosmetics containing allium extract is as follows.
여기서 우방자 추출물은 실시예 6의 것을 말한다.Here, the alliance extract refers to that of Example 6.
처방예 5Prescription Example 5
우방자 추출물을 함유한 화장료중 맛사지크림의 처방예는 다음과 같다.A prescription example of a massage cream in cosmetics containing allium extract is as follows.
여기서 우방자 추출물은 실시예 6의 것을 말한다.Here, the alliance extract refers to that of Example 6.
처방예 6Prescription Example 6
우방자 추출물을 함유한 화장료중 에센스의 처방예는 다음과 같다.Prescription examples of essences in cosmetics containing allium extract are as follows.
여기서 우방자 추출물은 실시예 6의 것을 말한다.Here, the alliance extract refers to that of Example 6.
처방예 7Prescription Example 7
우방자 추출물을 함유한 화장료중 팩의 처방예는 다음과 같다.Prescription examples of packs in cosmetics containing allium extract are as follows.
여기서 우방자 추출물은 실시예 6의 것을 말한다.Here, the alliance extract refers to that of Example 6.
본 발명의 항산화 화장료는 자유 라디칼에 의한 생체물질의 산화를 억제하여 피부의 노화를 방지 또는 지연시킨다.Antioxidant cosmetics of the present invention inhibit the oxidation of biological material by free radicals to prevent or delay aging of the skin.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980062135A KR100570118B1 (en) | 1998-12-30 | 1998-12-30 | Antioxidant Cosmetics Containing Allium Extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980062135A KR100570118B1 (en) | 1998-12-30 | 1998-12-30 | Antioxidant Cosmetics Containing Allium Extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000045575A true KR20000045575A (en) | 2000-07-25 |
KR100570118B1 KR100570118B1 (en) | 2006-07-27 |
Family
ID=19568829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019980062135A KR100570118B1 (en) | 1998-12-30 | 1998-12-30 | Antioxidant Cosmetics Containing Allium Extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100570118B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020046615A (en) * | 2000-12-15 | 2002-06-21 | 유상옥,송운한 | Skin whitening composition containing arctium lappa extracts |
KR20030092519A (en) * | 2002-05-30 | 2003-12-06 | 주식회사 리젠 바이오텍 | Composition for improving or preventing of allergic dermatological diseases |
KR100901661B1 (en) * | 2007-07-13 | 2009-06-08 | 바이오스펙트럼 주식회사 | Compositions for Improving Skin Wrinkle Comprising Arctigenin as an Active Ingredient |
CN106176468A (en) * | 2016-08-31 | 2016-12-07 | 百朗德生物化学(海门)有限公司 | A kind of antipollution cosmetic composition and preparation method thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101442751B1 (en) * | 2012-12-13 | 2014-09-24 | 주식회사 코리아나화장품 | Topical Composition For Promoting Lipid Biosynthesis Comprising Arctium lappa seed extract As Active Ingredient |
KR20200140921A (en) * | 2018-09-20 | 2020-12-16 | 김숙경 | Composition for the prevention or treatment of skin aging or dermatitis comprising extracts of Gyeji, gold and silver flowers, scented oil, Schisandra chinensis, wubangja, and Mokdanpi, and method using the same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60214721A (en) * | 1984-04-06 | 1985-10-28 | Inahata Koryo Kk | Cosmetic composition for preventing liver-spot |
JP3481652B2 (en) * | 1993-07-14 | 2003-12-22 | 三省製薬株式会社 | External preparation for skin |
JPH09249578A (en) * | 1996-03-18 | 1997-09-22 | Yakurigaku Chuo Kenkyusho:Kk | Clinical application of crude drug extract using tyrosinase activity as index |
JPH09255517A (en) * | 1996-03-19 | 1997-09-30 | Noevir Co Ltd | Antibacterial low irritating cosmetic material |
-
1998
- 1998-12-30 KR KR1019980062135A patent/KR100570118B1/en not_active IP Right Cessation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020046615A (en) * | 2000-12-15 | 2002-06-21 | 유상옥,송운한 | Skin whitening composition containing arctium lappa extracts |
KR20030092519A (en) * | 2002-05-30 | 2003-12-06 | 주식회사 리젠 바이오텍 | Composition for improving or preventing of allergic dermatological diseases |
KR100901661B1 (en) * | 2007-07-13 | 2009-06-08 | 바이오스펙트럼 주식회사 | Compositions for Improving Skin Wrinkle Comprising Arctigenin as an Active Ingredient |
CN106176468A (en) * | 2016-08-31 | 2016-12-07 | 百朗德生物化学(海门)有限公司 | A kind of antipollution cosmetic composition and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR100570118B1 (en) | 2006-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101402550B1 (en) | Antioxidizing Functional Cosmetic Compositions for Containing Extracted/Fermented Dendropanax morbifera Products and Functional Cosmetics Produced Thereby | |
KR101083275B1 (en) | Whitening agent skin preparation for external use and cosmetic | |
KR102088728B1 (en) | Cosmetic Composition for Improving Skin Elasticity and Winkles Comprising Plant Complex Extracts as Active Ingredient | |
KR101664025B1 (en) | Cosmetic composition containing natural herb extracts | |
KR102009486B1 (en) | Cosmetic composition for anti-aging containing fermented extract complex | |
KR20200104158A (en) | Cosmetic composition comprising centella asiatica extracts cultivated by aquaponics | |
KR101898250B1 (en) | Cosmetic composition for skin whitening comprising the Ilex integra extract | |
KR100570118B1 (en) | Antioxidant Cosmetics Containing Allium Extract | |
KR20190058059A (en) | A cosmetic composition comprising soybean sprout by product extract | |
KR100570120B1 (en) | Free radical scavenging cosmetics containing hawthorn extract | |
KR20000045573A (en) | Anti-oxidant cosmetic composition containing the extract of forsythia fructus | |
KR100782517B1 (en) | Antioxidant or skin irritation-relieving cosmetic composition containing plant extracts | |
KR20190048935A (en) | Cosmetic composition comprising extract of red onion fermented by aureobasidium pullulans | |
KR101618595B1 (en) | Immature tomato hydrolysates that have high tomatidine content, preparation method thereof and cosmetic composition containing the same | |
KR20190049067A (en) | A cosmetic composition comprising extract of coffee silver skin and coffee grounds | |
KR100570117B1 (en) | Cosmetics for free radical scavenging containing gold extract | |
KR101176525B1 (en) | Cosmetic Composition Comprising Acer tegmentosum Maxim as Active Ingredient | |
KR20040087644A (en) | Cosmetic Composition Comprising Pyrus communis L. Extract for Skin Whitening | |
KR20090056522A (en) | Cosmetic composition having free radical scavenging activity comprising the extract of citrus aurantium, hypericum sampsonii hance, taxillus chinensis, ligustrum lucidum, lycium chinense as active ingredient | |
KR20110122448A (en) | Cosmetic composition comprising the extract of filipendula formosa as active ingredient | |
KR20110078536A (en) | Cosmetic composition comprising the extract of spiraea prunifolia var.simpliciflora as active ingredient | |
KR20150132753A (en) | A preparation method of a leaf extract of Morus alba having antioxidant and antimicrobial activity | |
KR20010018665A (en) | A cosmetic composition containing Bambusae caulis in Taenian extracts | |
KR102533787B1 (en) | Antioxidant effect on flavonoids and polyphenols of Ceratopteris thalictroides extract, and cosmetic composition for preventing skin aging, or for preventing or improving skin wrinkles | |
KR102318606B1 (en) | Cosmetic composition for skin antioxidant with extract of Osmanthus insularis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130401 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140312 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160329 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170329 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180329 Year of fee payment: 13 |
|
EXPY | Expiration of term |